Cervical Cancer: Cervical cancer treatment possible, India will soon be able to vaccinate
Cervical Cancer Vaccine: Cervical cancer i.e. cancer of the cervix causes one death every 5 minutes in the world. Leakage of dirty water from the uterus, irregular menstruation, more pain in the back or legs, or obstruction in urine is its initial symptoms.
80,000 people die of cervical cancer in India in a year. (Representational photo: Pixabay)
New Delhi. Scientists have got great success regarding Cervical cancer. The head of NTAGI has informed us that cervical cancer can be cured by the HPV vaccine. NK Arora, head of the National Technical Advisory Group on Immunization, has informed news agency ANI that the HPV vaccine can cure cervical cancer and soon this vaccine will be administered to girls in India. He told that India will soon be able to introduce the HPV vaccine to girls aged 9-14 years in a national program.
NK Arora told that after the age of 35, screening for cervical disease is very important. He said that treatment can be possible only at the PHC if it is identified initially. This screening needs to be taken as a mission. Arora said that India has the highest number of deaths due to cervical cancer globally. Arora told that 80,000 people die of cervical cancer in India in a year. Cervical cancer is the second most common cancer in India among women aged 15 to 44 years.
Work is also being done on the Zika virus vaccine
Along with this, NK Arora told that the work of making a vaccine for the Zika virus is also being done. He said, “We are trying whether the Zika vaccine can be manufactured in India as well. We are monitoring pregnant women and their children.”
Earlier in November, pharma company Cipla introduced 22.5 mg Leuprolide Acetate Injection Depot for the treatment of prostate cancer. The US Food and Drug Administration (USFDA) had already approved this product through the New Drug Application (NDA) regulatory route.